MarketLens
Sign Up

Boston Scientific's Restructuring: A Cost-Cutting Gambit Amidst Deeper MedTech Headwinds

3 months ago
SHARE THIS ON:

Boston Scientific's Restructuring: A Cost-Cutting Gambit Amidst Deeper MedTech Headwinds

Exclusive Content for Pro Members

Pro members only. Upgrade to access this article, premium analysis, and stock recommendations.

SHARE THIS ON:

Related Articles

Category

You may also like

Stock News•1 week ago

Boston Scientific Q3 Earnings Call Highlights

Boston Scientific's Q3 2026 results fell below prior guidance after an eight-day cybersecurity incident disrupted manufacturing and shipments, with competitive and pricing pressures also weighing on k...
Stock News•2 months ago

Boston Scientific's ICVT Business Gains Momentum: Can Growth Continue?

Boston Scientific's ICVT sales rose 15% as coronary therapies gained traction. New devices and deals could extend growth momentum, though sustainability depends on continued adoption and execution.
Stock News•3 months ago

Boston Scientific unveils new restructuring plan, expects job cuts

Boston Scientific announced a new company-wide restructuring plan approved by its board, expecting job cuts to reduce costs and position for future growth, per a Monday regulatory filing.

Breaking News

View All →

Top Headlines

View More →
Stock News•1 hour ago

ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Alphabet Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - GOOGL, GOOG

Stock News•2 hours ago

Stock Market Today, Nov. 4: Amazon Jumps 6% From New Perspective on AWS Growth and AI Strategy Following Election Results

Stock News•2 hours ago

Apple (AAPL)) Price Forecast: Record High Follows Dramatic Reversal

Stock News•2 hours ago

Apple cements its status as tech's biggest heavyweight with the stock's best day in over a year

Stock News•3 hours ago

Here's What a $1,000 Investment in AMD Could Be Worth by 2030